Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
Recruiting · NCT07704658 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors | Head and Neck Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, endocrine system disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Phase 4 | 2026-08-10 | NCT07704658 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rigel Pharmaceuticals | 13 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Universitario HM Sanchinarro | Madrid | Spain | 45 |
| Hospital Universitario San Pedro | Logroño | Spain | 5 |